These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 449915)

  • 1. Immune interferon in the circulation of patients with autoimmune disease.
    Hooks JJ; Moutsopoulos HM; Geis SA; Stahl NI; Decker JL; Notkins AL
    N Engl J Med; 1979 Jul; 301(1):5-8. PubMed ID: 449915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Laboratory diagnosis of polysystemic autoimmune diseases].
    Sipka S
    Orv Hetil; 2005 Feb; 146(9):403-9. PubMed ID: 15830607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease.
    Lyons R; Narain S; Nichols C; Satoh M; Reeves WH
    Ann N Y Acad Sci; 2005 Jun; 1050():217-28. PubMed ID: 16014537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
    Riemekasten G; Hiepe F
    Z Arztl Fortbild (Jena); 1992 Mar; 86(5):217-22. PubMed ID: 1585674
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases].
    Monegat JN; Joller-Jemelka HI; Grob PJ
    Schweiz Med Wochenschr; 1974 Nov; 104(45):1614-23. PubMed ID: 4612703
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders.
    Theander E; Jacobsson LT
    Rheum Dis Clin North Am; 2008 Nov; 34(4):935-47, viii-ix. PubMed ID: 18984413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A syndrome of multiple immune autoreactivity. A breakdown in immune regulation.
    Diaz LA; Glamb RW; Silva J
    Arch Dermatol; 1980 Jan; 116(1):77-9. PubMed ID: 6986118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
    Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
    J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
    Ebo D; DeClerck LS; Bridts CH; Stevens WJ
    In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity, autoimmunity and autoimmune diseases in older people.
    Rosato E; Salsano F
    J Biol Regul Homeost Agents; 2008; 22(4):217-24. PubMed ID: 19036223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viruses and autoimmune disease.
    Vaughan JH
    J Rheumatol; 1996 Nov; 23(11):1831-3. PubMed ID: 8923350
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemorheologic disturbances and circulating immune complexes in patients with rheumatic diseases].
    Loskutova TT; Koreshkov GG; Nasonov EL; Zakharchenko VN; Larionov SM
    Ter Arkh; 1989; 61(5):51-5. PubMed ID: 2781490
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases.
    Feldmann JL; Becker MJ; Moutsopoulos H; Fye K; Blackman M; Epstein WV; Talal N
    J Clin Invest; 1976 Jul; 58(1):173-9. PubMed ID: 6490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
    Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Natural biological models of autoimmune diseases].
    Pleskovskaia GN
    Revmatologiia (Mosk); 1991; (4):38-44. PubMed ID: 1805332
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inflammatory rheumatism within the framework of autoimmune diseases].
    Van Slype J
    J Belge Rhumatol Med Phys; 1967; 22(4):204-7. PubMed ID: 4185872
    [No Abstract]   [Full Text] [Related]  

  • 19. IgG subclasses of autoantibodies in systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity.
    Rubin RL; Tang FL; Chan EK; Pollard KM; Tsay G; Tan EM
    J Immunol; 1986 Oct; 137(8):2528-34. PubMed ID: 3760566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Circulating interferon in patients with systemic lupus erythematosus. A prospective study].
    Dudli C; Kaiser V; Aguet M; Joller H; Pichler WI; Grob PJ; Fontana A
    Schweiz Med Wochenschr; 1986 Jan; 116(4):104-9. PubMed ID: 2419975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.